Project Grant HT94252510962
Award Date 9/1/25
Completion Date 8/31/29
Dollars Obligated $2.9M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Aurora, CO 80045, USA
Similar Awards
- This $2,488,002.00 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports a multi-year research effort by the University of Colorado-Denver to develop biomarkers for detecting acute, subacute, and chronic organ injury following neonatal congenital heart disease surgery. The research aims to improve diagnostic capabilities and treatment outcomes for this patient population. The award runs from April 1, 2024 to March 31, 2028, and...
- This federal Project Grant award of $1,314,065.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research on the dose-response relationship of acute traumatic brain injury (TBI) blood biomarkers with pathoanatomic neuroimaging findings. The project will be conducted by the University of California, San Francisco (UCSF) over a period of 3 years from September 1, 2025 to August 31, 2028. The research...
- The University of Colorado was awarded a $1,586,723 project grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from July 1, 2022 to June 30, 2026 to investigate the role of microglia in sleep disturbances following a traumatic brain injury. Through this funding, the University of Colorado aims to transform military and public health by gaining medical insights on the...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $2,699,157.00 to the University of Pittsburgh to evaluate the effectiveness of a traumatic brain injury whole blood test in improving assessment and triage for patients with mild traumatic brain injury presenting to civilian emergency departments. The project aims to generate data to support the clinical application of this diagnostic test, which...
- This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is focused on identifying diagnostic biomarkers related to the cerebrovascular contributions to cognitive impairment in repeated blast concussion. The $1,999,996.00 grant was awarded to Temple University on June 1, 2025, with a planned completion date of May 31, 2029. The research is expected to transform healthcare for military service members, veterans, and the...
- This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $2,583,160.00 to Virginia Commonwealth University to optimize diagnostics and healthcare costs for mild traumatic brain injury (mTBI) across the military. The project aims to develop a mathematical framework and clinical decision support tool to improve mTBI diagnosis and care. The award period runs from September 30, 2025 to September 29, 2029. As a...
- The Defense Health Agency awarded a $320,000 Project Grant to the Regents of the University of Colorado Denver under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from August 1, 2023 to July 31, 2025 to determine the mechanisms underlying remyelination by surviving oligodendrocytes. The research aims to advance understanding of how the central nervous system repairs myelin sheaths, with potential implications for treating multiple...
- This $608,353 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund a longitudinal study by Craig Hospital's Research Department on resilience-related factors influencing psychosocial growth after traumatic brain injury. The study, titled "THRIVING AFTER TBI: A LONGITUDINAL INVESTIGATION OF RESILIENCE-RELATED FACTORS FOR PSYCHOSOCIAL GROWTH AFTER TRAUMATIC BRAIN INJURY," will be conducted over a 3-year...
- This $6,214,900 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program supports research on the role of genetic risk factors and immune response on neurovascular unit (NVU) function in post-traumatic brain injury (TBI) cognitive impairment. The primary awardee, the Scintillon Institute, a non-profit biomedical research organization in San Diego, California, will conduct this advanced scientific investigation over...
- This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $569,851 to the University of Pittsburgh to conduct research on the effectiveness of a traumatic brain injury whole blood test for improving assessment and triage of patients with mild traumatic brain injury in civilian emergency departments. The 4-year project, running from July 1, 2025 to June 30, 2029, aims to generate critical insights on how this novel...